12. Mooney, C. J.; Nagaiah, G.; Fu, P.; Wasman, J. K.; Cooney, M.
M.; Savvides, P. S.; Bokar, J. A.; Dowlati, A.; Wang, D.;
Agarwala, S. S.; Flick, S. M.; Hartman, P. H.; Ortiz, J. D.;
Lavertu, P. N.; Remick, S. C. Thyroid 2009, 19, 233.
4.2.5. Dynamic 3D-solution structure of 1
Details of this analysis, which utilised the methodology of
Blundell et al.,51 are provided in the Supplementary Material.
13. (a) Rustin, G. J.; Shreeves, G.; Nathan, P. D.; Gaya, A.; Ganesan,
T. S.; Wang, D.; Boxall, J.; Poupard, L.; Chaplin, D. J.; Stratford,
M. R. L.; Balkissoon, J.; Zweifel, M. Br. J. Cancer 2010, 102,
1355; (b) Ng, Q.-S.; Mandeville, H.; Goh, V.; Alonzi, R.; Milner,
J.; Carnell, D.; Meer, K.; Padhani, A. R.; Saunders, M. I.; Hoskin,
P. J. Ann. Oncol. 2012, 23, 231; (c) Nathan, P.; Zweifel, M.;
Padhani, A. R.; Koh, D.-M.; Ng, M.; Collins, D. J.; Harris, A.;
Carden, C.; Smythe, J.; Fisher, N.; Taylor, N. J.; Stirling, J. J.; Lu,
S.-P.; Leach, M. O.; Rustin G. J. S.; Judson, I. Clin. Cancer Res.
2012, 18, 3428.
14. Patterson, D. M.; Zweifel, M.; Middleton, M. R.; Price, P. M.;
Folkes, L. K.; Stratford, M. R. L.; Ross, P.; Halford, S.; Peters, J.;
Balkissoon, J.; Chaplin, D. J.; Padhani, A. R.; Rustin, G. J. S.
Clin. Cancer Res. 2012, 18, 1415.
15. (a) Eskens, F. A. L. M.; Tresca, P.; Tosi, D.; Van Doorn, L.;
Fontaine, H.; Van der Gaast, A.; Veyrat-Follet, C.; Oprea, C.;
Hospitel, M.; Dieras, V. Br. J. Cancer 2014, 110, 2170; (b)
Bahleda, R.; Sessa, C.; Del Conte, G.; Gianni, L.; Capri, G.;
Varga, A.; Oprea, C.; Daglish, B.; Hospitel, M.; Soria, J.-C.
Invest. New Drugs 2014, 32, 1188.
Acknowledgments
We are grateful to The University of Manchester Intellectual
Property (UMIP) for funding this work, the TINHAT project,
through a Proof-of-Principle award, and we warmly thank Dr
Richard Price and Dr Sunita Jones of UMIP for their constant
support, guidance and encouragement. We also thank Prof.
Ludwig Neyses and Dr Elizabeth Cartwright (Institute of
Cardiovascular Sciences, University of Manchester), Dr Ian
Crocker (Institute of Human Development, University of
Manchester), Prof. Alan McGown (University of Salford) and Dr
Charles Blundell (C4X Discovery Ltd.) for their significant
contributions to this project. We are also grateful to Darren Cook
(University of Salford) and Patricia Cooper (University of
Bradford) for assistance with compound testing, and to the staff
of the analytical services of School of Chemistry (University of
Manchester), especially Gareth Smith (MS), Steve Kelly (NMR)
16. (a) Rischin, D.; Bibby, D. C.; Chong, G.; Kremmidiotis, G.;
Leske, A. F.; Matthews, C. A.; Wong, S. S.; Rosen, M. A.; Desai,
J. Clin. Cancer Res. 2011, 17, 5152; (b) Nowak, A. K.; Brown, C.;
Millward, M. J.; Creaney, J.; Byrne, M. J.; Hughes, B.;
Kremmidiotis, G.; Bibby, D. C.; Leske, A. F.; Mitchell, P. L. R.;
Pavlakis, N.; Boyer, M.; Stockler, M. R. Lung Cancer, 2013, 81,
422.
and Martin Jennings (Microanalysis).
We also wish to
acknowledge the use of the EPSRC-funded Chemical Database
Service at Daresbury.59
17. (a) Mita, M. M.; Spear, M. A.; Yee, L. K.; Mita, A. C.; Heath, E.
I.; Papadopoulos, K. P.; Federico, K. C.; Reich, S. D.; Romero,
O.; Malburg, L.; Pilat, M.; Lloyd, G. K.; Neuteboom, S. T. C.;
Cropp, G.; Ashton, E.; LoRusso, P. M. Clin. Cancer Res. 2010,
16, 5892; (b) Yamazaki, Y.; Sumikura, M.; Hidaka, K.; Yasui, H.;
Kiso, Y.; Yakushiji, F.; Hayashi,Y. Bioorg. Med. Chem. 2010, 18,
3169; (c) Millward, M.; Mainwaring, P.; Mita, A.; Federico, K.;
Lloyd, G. K.; Reddinger, N.; Nawrocki, S.; Mita, M.; Spear, M. A.
Invest. New Drugs 2012, 30, 1065.
18. (a) Lickliter, J. D.; Francesconi, A. B.; Smith, G.; Burge, M.;
Coulthard, A.; Rose, S.; Griffin, M.; Milne, R.; McCarron, J.;
Yeadon, T.; Wilks, A.; Cubitt, A.; Wyld, D. K.; Vasey, P. A. Br.
J. Cancer 2010, 103, 597; (b) Burge, M.; Francesconi, A. B.;
Kotasek, D.; Fida, R.; Smith, G.; Wilks, A.; Vasey, P. A.;
Lickliter, J. D. Invest New Drugs 2013, 31, 126.
References and notes
1. Part 1: Edwards, D. J.; Hadfield, J. A.; Wallace, T. W.; Ducki, S.
Org. Biomol. Chem. 2011, 9, 219.
2. (a) Siemann, D. W.; Chaplin, D. J.; Horsman, M. R. Cancer 2004,
100, 2491; (b) Siemann, D. W.; Bibby, M. C.; Dark, G. G.;
Dicker, A. P.; Eskens, F. A. L. M.; Horsman, M. R.; Marmé, D.;
LoRusso, P. M. Clin. Cancer Res. 2005, 11, 416; (c) Siemann, D.
W.; Chaplin, D. J. Expert Opin. Drug Discovery 2007, 2, 1357; (d)
Sebahar, P. R.; Willardsen, J. A.; Anderson, M. B. Curr. Bioact.
Compd. 2009, 5, 79; (e) Horsman, M. R.; Bohn, A. B.; Busk, M.
Exp. Oncol. 2010, 32, 143.
3. (a) Folkman, J. Nat. Rev. Drug Discovery 2007, 6, 273; (b)
Sennino, B.; McDonald, D. M. Nat. Rev. Cancer 2012, 12, 699.
4. Ferrara, N.; Hillan, K. J.; Gerber, H.-P.; Novotny, W. Nat. Rev.
Drug Discovery 2004, 3, 391.
5. (a) Tozer, G. M.; Kanthou, C.; Baguley, B. C. Nat. Rev. Cancer
2005, 5, 423; (b) Horsman, M. R.; Siemann, D. W. Cancer Res.
2006, 66, 11520; (c) Kanthou, C.; Tozer, G. M. Int. J. Exp. Path.
2009, 90, 284; (d) Schwartz, E. L. Clin. Cancer Res. 2009, 15,
2594; (e) McKeage, M. J.; Baguley B. C. Cancer 2010, 116, 1859;
(f) Siemann, D. W. Cancer Treat. Rev. 2011, 37, 63.
19. Gramza, A. W.; Balasubramaniam, S.; Tito Fojo, A.; Ward, J.;
Wells, S. A. J. Clin. Oncol. 2013, 31 (May 20 supplement); ASCO
meeting abstract 6074.
20. (a) Ravelli, R. B. G.; Gigant, B.; Curmi, P. A.; Jourdain, I.;
Lachkar, S.; Sobel, A.; Knossow, M. Nature 2004, 428, 198; (b)
Gigant, B.; Wang, C.; Ravelli, R. B. G.; Roussi, F.; Steinmetz, M.
O.; Curmi, P. A.; Sobel, A.; Knossow, M. Nature 2005, 435, 519;
(c) Dorléans, A.; Gigant, B.; Ravelli, R. B. G.; Mailliet, P.; Mikol,
V.; Knossow, M. Proc. Natl. Acad. Sci. USA 2009, 106, 13775.
21. (a) Lampidis, T. J.; Kolonias, D.; Savaraj, N.; Rubin, R. W. Proc.
Natl. Acad. Sci. USA 1992, 89, 1256; (b) Webster, D. R.
Cardiovasc. Toxicol. 2002, 2, 75; (c) Motlagh, D.; Alden, K. J.;
Russell, B.; García, J. J. Physiol. 2002, 540.1, 93.
22. Mikaelian, I.; Buness, A.; de Vera-Mudry, M.-C.; Kanwal, C.;
Coluccio, D.; Rasmussen, E.; Downing, J. C.; Char, H. W.; Hilton,
H.; Funk, J.; Hoflack, J.-C.; Fielden, M.; Herting, F.; Suter-Dick,
L. Toxicol. Sci. 2010, 117, 144.
23. (a) Cooney, M. M.; Radivoyevitch, T.; Dowlati, A.; Overmoyer,
B.; Levitan, N.; Robertson, K.; Levine, S. L.; DeCaro, K.;
Buchter, C.; Taylor, A.; Stambler, B. S.; Remick, S. C. Clin.
Cancer Res. 2004, 10, 96; (b) Varterasian, M.; Fingert, H.; Agin,
M.; Meyer, M. Clin. Cancer Res. 2004, 10, 5967; (c) Ke, Q.;
Bodyak, N.; Rigor, D. L.; Hurst, N. W.; Chaplin, D. J.; Kang, P.
M. Vascul. Pharmacol. 2009, 51, 337.
24. (a) Van Heeckeren, W. J.; Bhakta, S.; Ortiz, J.; Duerk, J.; Cooney,
M. M.; Dowlati, A.; McCrae, K.; Remick, S. C. J. Clin. Oncol.
2006, 24, 1485; (b) Strevel, E. L.; Ing, D. J.; Siu, L. L. J. Clin.
Oncol. 2007, 25, 3362; (c) Subbiah, I. M.; Lenihan, D. J.;
Tsimberidou, A. M. The Oncologist 2011, 16, 1120.
25. (a) Colombel, V.; Joncour, A.; Thoret, S.; Dubois, J.; Bignon, J.;
Wdzieczak-Bakala, J.; Baudoin, O. Tetrahedron Lett. 2010, 51,
3127; (b) Colombel, V.; Baudoin, O. J. Org. Chem. 2009, 74,
4329; (c) Joncour, A.; Décor, A.; Thoret, S.; Chiaroni, A.;
6. Edwards, D. J.; Pritchard, R. G.; Wallace, T. W. Acta Crystallogr.,
Sect. B: Struct. Sci. 2005, 61, 335.
7. (a) Brossi, A. J. Med. Chem. 1990, 33, 2311; (b) Shi, Q.; Verdier-
Pinard, P.; Brossi, A.; Hamel, E.; Lee, K.-H. Bioorg. Med. Chem.
1997, 5, 2277; (c) Bhattacharyya, B.; Panda, D.; Gupta, S.;
Banerjee, M. Med. Res. Rev. 2008, 28, 155.
8. Kang, G. J.; Getahun, Z.; Muzaffar, A.; Brossi, A.; Hamel, E. J.
Biol. Chem. 1990, 265, 10255.
9. (a) Davis, P. D.; Dougherty, G. J.; Blakey, D. C.; Galbraith, S. M.;
Tozer, G. M.; Holder, A. L.; Naylor, M. A.; Nolan, J.; Stratford,
M. R.; Chaplin, D. J.; Hill, S. A. Cancer Res. 2002, 62, 7247; (b)
Blakey, D. C.; Westwood, F. R.; Walker, M.; Hughes, G. D.;
Davis, P. D.; Ashton, S. E.; Ryan, A. J. Clin. Cancer Res. 2002, 8,
1974; (c) Beerepoot, L. V.; Radema, S. A.; Witteveen, E. O.;
Thomas, T.; Wheeler, C.; Kempin, S.; Voest, E. E. J. Clin. Oncol.
2006, 24, 1491.
10. (a) Gould, S.; Westwood, F. R.; Curwen, J. O.; Ashton, S. E.;
Roberts, D. W.; Lovick, S. C.; Ryan, A. J. J. Natl. Cancer Inst.
2007, 99, 1724; (b) LoRusso, P. M.; Gadgeel, S. M.; Wozniak, A.;
Barge, A. J.; Jones, H. K.; DelProposto, Z. S.; DeLuca, P. A.;
Evelhoch, J. L.; Boerner, S. A.; Wheeler, C. Invest. New Drugs
2008, 26, 159.
11. For reviews, see (a) Mita, M. M.; Sargsyan, L.; Mita, A. C.; Spear,
M. Expert Opin. Investig. Drugs 2013, 22, 317; (b) Kretzschmann,
V. K.; Fürst, R. Phytochem. Rev. 2014, 13, 191.